Research programme: echinacea-derived immunostimulating compounds - MolecularNature Limited

Drug Profile

Research programme: echinacea-derived immunostimulating compounds - MolecularNature Limited

Alternative Names: Echinacea-derived bio-active compounds - MolecularNature Limited; Echinacea-derived immunostimulating compounds - MolecularNature Limited

Latest Information Update: 20 Sep 2011

Price : $50

At a glance

  • Originator MNLpharma
  • Class
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Autoimmune disorders

Most Recent Events

  • 06 Sep 2005 Preclinical trials in Autoimmune disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top